Tuesday 6 August 2013: FOR IMMEDIATE RELEASE Al Noor Hospitals Group Plc Results for the Six Months Ended 30 June 2013 First results as a public company in line with management expectations The Board continues to view the outlook with confidence London and Abu Dhabi: Al Noor Hospitals Group Plc (ANHA.L; the "Company" or "Al Noor"), the largest private healthcare service provider in Abu Dhabi, today announces its results for the six months ended 30 June 2013. Financial summary – All figures in US$ H1 2013 (US $) H1 2102 (US $) Change Revenue $179.5m $161.9m +10.9% Underlying Operating Profit (1) $37.7m $32.5m +15.9% Underlying EBITDA (1,2) $41.3m $37.0m +11.6% (1) before IPO costs (2) represents operating profit after adding back depreciation of $3.6m for H1 2013 and $4.5m for H1 2012 After listing on the London Stock Exchange in June, raising primary proceeds of US$150m, the company repaid all outstanding loans. Its net cash position of at the end of the period was US$88m. Operational highlights Outpatient volumes rose from 768,009 to 843,375, a 9.8% increase; Inpatient volumes increased by 18.7% from 17,280 to 20,516; Number of Revenue-Generating Doctors up by 45, a 12.9% increase; In H1, three new medical centres were commissioned at Mamura in Abu Dhabi, Sanaya in Al Ain and Muscat in the Sultanate of Oman, bringing the total number of centres to 10. 1 Dr. Kassem Alom, CEO, Al Noor Hospitals Group Plc said: “Following a successful listing, I am pleased to announce that our first results as a public company have shown strong growth. We operate in one of the fastest growing sectors in the Gulf region due to a rapidly ageing demographic, an increasing incidence of lifestyle-related medical conditions such as diabetes and obesity, and service gaps in the current healthcare market. Our growth strategy will continue to focus on meeting the strong demand driven by these three factors.” “Trading in the second half of the year has begun in line with management expectations. We remain on track to deliver strong growth through our physician hiring programme and the opening of two more Medical Centres. As a result, we are looking forward to the future with considerable confidence.” “I would like to take this opportunity to thank our new investors for placing their trust with us and for seeing our potential to drive shareholder value, and our founding investors for their continued support of the business.” “I would also like to thank our employees and my colleagues in management for their efforts in achieving a successful IPO and for laying the foundations for future growth.” Outlook Al Noor is performing in line with our expectations, and we are on track to achieve our objectives for 2013. We continue to pay special attention to physician recruitment and licensing, and we are on course to open two additional medical centres in the second half of the year. We operate in one of the fastest growing sectors in the Gulf region due to a rapidly ageing demographic, an increasing incidence of lifestyle-related medical conditions such as diabetes and obesity, and service gaps in the current healthcare market. Our growth strategy will continue to focus on meeting the strong demand driven by these three factors. The Board continues to view the outlook with confidence. Analyst and Investor Call There will be a call for analysts and investors today at 09:00am BST / 12:00 UAE, details of which are as follows: Dial-in number: +44 (0) 1452 555 566 Caller ID: 27293294# For further information, please contact: Al Noor Hospitals Group plc Dr Sami Alom +971 2 406 6992 Pramod Balakrishnan +971 2 406 6945 2 Brunswick Group Jon Coles / Craig Breheny +44 20 7404 5959 Rupert Young / Jeehan Balfaqaih +971 4 446 6270 Cautionary statement These Interim Results have been prepared solely to provide additional information to shareholders to assess the Group’s performance in relation to its operations and growth potential. These Interim Results should not be relied upon by any other party or for any other reason. Any forward looking statements made in this document are done so by the directors in good faith based on the information available to them up to the time of their approval of this report. However, such statements should be treated with caution due to the inherent uncertainties, including both economic and business risk factors, underlying any such forward- looking information. About Al Noor Al Noor Hospitals Group Plc provides primary, secondary and tertiary care in the Emirate of Abu Dhabi and the wider region through its portfolio of hospitals and medical centres. As of 30 June 2013, the company had 227 operational beds and 504 physicians, more than any other private competitor in Abu Dhabi. Al Noor was the first private hospital in Abu Dhabi City to obtain Joint Commission International (“JCI”) accreditation, and today all of its hospitals are accredited. The company is listed in on the London Stock Exchange (ticker: ANHA.L) For more information, please go to www.alnoorhospital.com. 3 CEO’s review Al Noor delivered a strong operational result for the first half of the year with revenues, operating profits and underlying EBITDA all seeing double digit year-on-year growth and EBITDA margins remaining steady at 23%. We continue to work hard on hiring and retaining our Physicians, who are essential to our success. During the first six months we added 45 Revenue-Generating Physicians and this has contributed to the rise in both Outpatient and Inpatient Volumes during the period. To deliver sustainable growth, we are working passionately on enhancing the quality of our services and improving the overall patient experience at our Hospitals and Medical Centres. At the Khalifa Hospital, as part of the growth plans we are looking to take up additional space in the existing building and enhancing the interiors of the premises to improve the patient experience. The Group has also commenced work on a phased implementation of SAP in conjunction with a leading systems integrator. This project is expected to run for the next 36 months with a phased implementation of various modules of SAP. During the first six months, three medical centres have been commissioned at Mamura in Abu Dhabi, Sanaya in Al Ain and Muscat in the Sultanate of Oman. We continue to make good progress on the two acquisition targets we disclosed in the prospectus and are confident of providing an update soon. We remain on track to deliver strong growth through our physician hiring programme and the opening of two more Medical Centres in the last quarter of 2013. Business Update Operating KPIs H1 2012 H1 2013 Change Outpatient Visits (1) 768,009 843,375 9.8% Average revenue per out-patient(US $) (2) 154 152 -1.3% Outpatient revenue (US $.m) (3) 122.6 133.9 9.2% In-patient admissions (1) 17,280 20,516 18.7% Average Revenue per in-patient (US $) (2) 2,280 2,225 -2.4% In-patient revenue (US $, m) 39.4 45.6 15.7% Total Revenue (US $,m) 161.9 179.5 10.9% Bed Occupancy Rate (4) 58% 68% 17.2% Average Length of Stay 1.77 1.74 -0.03 Physical KPIs H1 2012 H1 2013 Increase Avg. no of Operating Beds 226 227 1 Avg. no of Revenue Generating Doctors 328 371 43 Avg. no of Other support Doctors 82 97 15 Avg. no of Nursing Staff 645 749 104 4 Avg. no of other Medical Staff (5) 594 635 41 Avg. no of Admin Support Staff 1,650 1,592 -58 1 Excludes follow-up visits 2 Includes revenue from provision of medical and hospital services, laboratory, radiology and pharmacy services and excludes Proj, Commerical, and Other Misc. Income 3 Includes revenues from projects, Pharmacy, Commercial Division, and other Miscellaneous income. 4 Calculated by dividing the number of total in -patient nights by the number of bed days (number of days multiplied by number beds) available during the year. 5 Includes pharm acists, assistant pharmacists, technicians and other medical staff. Operating performance continued to improve, in line with our expectations. Revenue improved by 10.9% to $179.5m, Underlying EBITDA grew to $41.3m, representing an 11.7% increase on the same period last year, and Underlying EBITDA margin remained steady at 23.0%. FY2012 A H12012 A H12013 A Avg. No. of FTE Revenue-generating doctors 350 331 395 # growth since FY 2012A 45 % growth since FY 2012A 12.9% # growth since H1 2012A 64 % growth since H1 2012A 19.3% No. of Outpatient Encounters 1,505,518 768,009 843,375 % growth (since H1 2012A) 9.8% Inpatient / Outpatient encounters ( IP conversion ratio) 2.4% 2.2% 2.4% No. of In-patient Admissions 35,590 17,280 20,516 % growth (since H1 2012A) 18.7% Improved revenue was driven by higher outpatient and inpatient volumes, which were enabled by an increase in the number of revenue-generating physicians. We have been able to increase the number of physicians through significant improvements in recruiting and licensing processes. These improvements have also helped us recruit highly-trained physicians to offer new services to our patients. Underlying EBITDA margin remained steady, and we expect this trend to continue. In order to minimise interest costs, the entire debt on the balance sheet has been paid down, and the company had a cash balance of USD 88m at the end of H1. In addition, we have a committed USD81m working capital and acquisition revolver facility available for future use.